Mercer to buy Fundhouse’s UK business
Mercer, a business of Marsh McLennan, has agreed to acquire the UK operations of Fundhouse for an undisclosed sum.
Headquartered in London, Fundhouse offers investment advisory and model portfolio services for financial advisers and institutional wealth investors.
The deal awaits regulatory approval and is slated for completion in the third quarter of this year.
The transaction excludes Fundhouse’s South Africa operations.
In a statement, Mercer said the deal will bolster its capabilities in the UK wealth management industry and provide Fundhouse clients with access to Mercer’s UK-wide reach and global investment research resources.
Mercer UK CEO Benoit Hudon said: “This deal will allow us to use our combined strengths and resources to bring new, exciting ideas and investment opportunities to financial advisors and wealth managers in the UK.
“We look forward to working with the Fundhouse team and welcoming them to Mercer.”
Fundhouse, established in 2010 by CEO and chief investment officer Rory Maguire, managed £2.1bn ($2.84bn) in assets and advised on £10bn ($13.5bn) as of 1 May 2025.
Maguire will continue to lead Fundhouse’s investment process and move to Mercer, supported by the existing Fundhouse senior leadership team.
Maguire said: “In our new home at Mercer, we are aligning with a firm that shares our founding principles of deep fund research and excellent client service.
“The Fundhouse team is excited to continue doing what we do best – providing our clients with founder-led investment consulting and model portfolios – all strengthened by Mercer’s resources and capabilities.”
Last month, Mizuho Financial Group partnered with Mercer Japan and Mercer Investments (Japan) to offer outsourced chief investment officer (OCIO) services in Japan.
"Mercer to buy Fundhouse’s UK business" was originally created and published by Private Banker International, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Latest News
- SailPoint Lifts 2026 Forecast After Reporting 30% ARR Growth And Big Gains In High-Spending Customers
- Novo signs $812 million weight-loss drug license deal with US biotech Deep Apple
- Vanguard Expands Active Bond ETF Lineup. Here’s What to Know.
- CPI Inflation Is Very Tame Despite Trump Tariffs
- US consumer prices rise moderately in May
- Moody’s Ratings Brings Credit Rating to Solana in Real-World Asset Tokenization Trial